company background image
6712 logo

Ever Supreme Bio Technology TPEX:6712 Stock Report

Last Price

NT$192.50

Market Cap

NT$15.5b

7D

-2.0%

1Y

9.7%

Updated

14 Jun, 2024

Data

Company Financials

Ever Supreme Bio Technology Co., Ltd

TPEX:6712 Stock Report

Market Cap: NT$15.5b

6712 Stock Overview

Engages in the research, development, and manufacture of drug products related to human mesenchymal stem cells and immune cells.

6712 fundamental analysis
Snowflake Score
Valuation1/6
Future Growth0/6
Past Performance4/6
Financial Health6/6
Dividends1/6

Ever Supreme Bio Technology Co., Ltd Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Ever Supreme Bio Technology
Historical stock prices
Current Share PriceNT$192.50
52 Week HighNT$208.18
52 Week LowNT$154.55
Beta0.28
1 Month Change9.15%
3 Month Change3.29%
1 Year Change9.72%
3 Year Change-40.50%
5 Year Change50.18%
Change since IPO181.47%

Recent News & Updates

Recent updates

Is Ever Supreme Bio Technology's (GTSM:6712) Share Price Gain Of 126% Well Earned?

Mar 11
Is Ever Supreme Bio Technology's (GTSM:6712) Share Price Gain Of 126% Well Earned?

We're Hopeful That Ever Supreme Bio Technology (GTSM:6712) Will Use Its Cash Wisely

Jan 13
We're Hopeful That Ever Supreme Bio Technology (GTSM:6712) Will Use Its Cash Wisely

If You Had Bought Ever Supreme Bio Technology (GTSM:6712) Shares A Year Ago You'd Have Earned 24% Returns

Nov 17
If You Had Bought Ever Supreme Bio Technology (GTSM:6712) Shares A Year Ago You'd Have Earned 24% Returns

Shareholder Returns

6712TW BiotechsTW Market
7D-2.0%1.9%1.9%
1Y9.7%-2.1%27.4%

Return vs Industry: 6712 exceeded the TW Biotechs industry which returned -2.1% over the past year.

Return vs Market: 6712 underperformed the TW Market which returned 27.4% over the past year.

Price Volatility

Is 6712's price volatile compared to industry and market?
6712 volatility
6712 Average Weekly Movement4.0%
Biotechs Industry Average Movement4.8%
Market Average Movement4.7%
10% most volatile stocks in TW Market8.4%
10% least volatile stocks in TW Market2.2%

Stable Share Price: 6712 has not had significant price volatility in the past 3 months.

Volatility Over Time: 6712's weekly volatility (4%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
2016n/an/awww.ever-supreme.com.tw

Ever Supreme Bio Technology Co., Ltd engages in the research, development, and manufacture of drug products related to human mesenchymal stem cells and immune cells. Its products include UMC01, a drug candidate in Phase I clinical trials for the treatment of myocardial infarction and stroke; ADCV01, a drug candidate in Phase II clinical trials for the treatment of malignant brain tumor; CAR001, a chimeric antigen receptor immune cells product; and bone-marrow stem cells (BMSC), used to treat chronic stroke, degenerative osteoarthritis, and spinal cord injuries. The company was incorporated in 2016 and is based in Taichung, Taiwan.

Ever Supreme Bio Technology Co., Ltd Fundamentals Summary

How do Ever Supreme Bio Technology's earnings and revenue compare to its market cap?
6712 fundamental statistics
Market capNT$15.53b
Earnings (TTM)NT$445.92m
Revenue (TTM)NT$804.84m

34.8x

P/E Ratio

19.3x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
6712 income statement (TTM)
RevenueNT$804.84m
Cost of RevenueNT$246.12m
Gross ProfitNT$558.72m
Other ExpensesNT$112.80m
EarningsNT$445.92m

Last Reported Earnings

Mar 31, 2024

Next Earnings Date

n/a

Earnings per share (EPS)5.53
Gross Margin69.42%
Net Profit Margin55.40%
Debt/Equity Ratio0%

How did 6712 perform over the long term?

See historical performance and comparison

Dividends

2.8%

Current Dividend Yield

100%

Payout Ratio
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.